SPEVIGO

SPESOLIMAB-SBZO · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SPEVIGO, covering 2022-09-01 to 2026-04-14. Get the full timeline:

Most recent: EMA Authorised: Spevigo (spesolimab) — LEO Pharma A/S